---
title: 'Placebo and nocebo responses in painful diabetic neuropathy: systematic review
  and meta-analysis'
date: '2023-08-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37530658/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230802180849&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: This preregistered (CRD42021223379) systematic review and meta-analysis
  aimed to characterize the placebo and nocebo responses in placebo-controlled randomized
  clinical trials (RCTs) on painful diabetic neuropathy (PDN), updating the previous
  literature by a decade. Four databases were searched for PDN trials published in
  the past 20 years, testing oral medications, adopting a parallel-group design. Magnitude
  of placebo or nocebo responses, Cochrane risk of bias, heterogeneity, and ...
disable_comments: true
---
This preregistered (CRD42021223379) systematic review and meta-analysis aimed to characterize the placebo and nocebo responses in placebo-controlled randomized clinical trials (RCTs) on painful diabetic neuropathy (PDN), updating the previous literature by a decade. Four databases were searched for PDN trials published in the past 20 years, testing oral medications, adopting a parallel-group design. Magnitude of placebo or nocebo responses, Cochrane risk of bias, heterogeneity, and ...